Teresa Mattarelli
Corporate Officer/Principal at Perspectum Group Ltd.
Teresa Mattarelli active positions
| Companies | Position | Start | End |
|---|---|---|---|
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 2021-01-31 | - |
Career history of Teresa Mattarelli
Former positions of Teresa Mattarelli
| Companies | Position | Start | End |
|---|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 2015-12-31 | 2020-10-31 |
Training of Teresa Mattarelli
| McGill University | Masters Business Admin |
Statistics
International
| United Kingdom | 2 |
| Canada | 2 |
| Ireland | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Technology Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| Private companies | 1 |
|---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Teresa Mattarelli
- Experience
